Inventor · disambiguated record
Javier Fernando Chaparro Riggers
Also filed as: CHAPARRO-RIGGERS JAVIER FERNANDO
20 granted patents·13 pending applications·399 citations·filing 2009–2023
95Inventor score
Top patents by PatentIndex Score
33 records- 0197US8080243B2Isolated antibody which specifically binds to PCSK9LIANG HONG·Filed 2009·Granted Dec 20, 2011·139 cites·3 claims
- 0296US11814435B2Therapeutic antibodies and their usesPFIZER·Filed 2020·Granted Nov 14, 2023·5 cites·7 claims
- 0396US9969809B2Therapeutic antibodies and their usesPFIZER·Filed 2016·Granted May 15, 2018·44 cites·8 claims
- 0496US8426363B2Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9LIANG HONG·Filed 2011·Granted Apr 23, 2013·58 cites·13 claims
- 0596US8399646B2Isolated nucleic acid encoding an antibody which specifically binds to PCSK9 and a host cell that produces the antibodyLIANG HONG·Filed 2011·Granted Mar 19, 2013·57 cites·14 claims
- 0695US11155630B2Therapeutic antibodies and their usesPFIZER·Filed 2020·Granted Oct 26, 2021·3 cites·14 claims
- 0793US9029515B2Anti-PCSK9 antibodies with pH dependent antigen bindingPONS JAUME·Filed 2011·Granted May 12, 2015·43 cites·4 claims
- 0892US10294304B2Chimeric antigen receptors targeting B-cell maturation antigenPFIZER·Filed 2016·Granted May 21, 2019·16 cites·22 claims
- 0991US11059876B2IL-15 variants and uses thereofPFIZER·Filed 2019·Granted Jul 13, 2021·7 cites·36 claims
- 1091US10793635B2Therapeutic antibodies and their usesPFIZER·Filed 2018·Granted Oct 6, 2020·4 cites·13 claims
- 1189US10040860B2Therapeutic antibodies and their usesPFIZER·Filed 2018·Granted Aug 7, 2018·6 cites·8 claims
- 1286US9175093B2PCSK9 antagonistsRINAT NEUROSCIENCE CORP·Filed 2013·Granted Nov 3, 2015·6 cites·11 claims
- 1385US2024018252A1Therapeutic antibodies and their usesPFIZER·Filed 2023·Application pending·0 cites
- 1483US8715673B2Staphylococcus aureus specific antibodies and uses thereofRINAT NEUROSCIENCE CORP·Filed 2012·Granted May 6, 2014·4 cites·15 claims
- 1582US11312782B2Chimeric antigen receptors targeting B-cell maturation antigenPFIZER·Filed 2019·Granted Apr 26, 2022·1 cites·46 claims
- 1681US11702474B2Antibodies specific for CD47, PD-L1, and uses thereofPFIZER·Filed 2020·Granted Jul 18, 2023·1 cites·27 claims
- 1781US9248189B2Anti-glucagon receptor antibodies and pharmaceutical compositions thereofRINAT NEUROSCIENCE CORP·Filed 2014·Granted Feb 2, 2016·5 cites·14 claims
- 1873US11912776B2Chimeric antigen receptors targeting B-cell maturation antigenPFIZER·Filed 2022·Granted Feb 27, 2024·0 cites·24 claims
- 1966US2024124591A1Antibodies Specific for CD47, PD-L1, and Uses ThereofPFIZER·Filed 2023·Application pending·0 cites
- 2062US2021324028A1IL-15 Variants and Uses ThereofPFIZER·Filed 2021·Application pending·0 cites
- 2161US2024010696A1IL-12 Variants and Uses ThereofPFIZER·Filed 2023·Application pending·0 cites
- 2257US2020024366A1ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDINGPFIZER·Filed 2019·Application pending·0 cites
- 2356US2023365701A1Anti-lymphotoxin beta receptor antibodies and methods of use thereofPFIZER·Filed 2023·Application pending·0 cites
- 2455US12163169B2Inducible chimeric cytokine receptorsALLOGENE THERAPEUTICS INC·Filed 2019·Granted Dec 10, 2024·0 cites·8 claims
- 2554US2016096898A1Pc33718eRINAT NEUROSCIENCE CORP·Filed 2015·Application pending·0 cites
- 2648US2020399343A1Improved t cell compositions and methodsALLOGENE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2744US9249224B2Human growth hormone receptor antagonist antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2012·Granted Feb 2, 2016·0 cites·12 claims
- 2844US2015266974A1ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDINGRINAT NEUROSCIENCE CORP·Filed 2015·Application pending·0 cites
- 2941US2016311912A1Anti-glucagon receptor antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2015·Application pending·0 cites
- 3041US2019338015A1Cell death inducing chimeric antigen receptorsCELLECTIS·Filed 2017·Application pending·0 cites
- 3140US2023192839A1Antibodies having conditional affinity and methods of use thereofPFIZER·Filed 2018·Application pending·0 cites
- 3238US11198735B2Anti-GITR antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2018·Granted Dec 14, 2021·0 cites·6 claims
- 3328US2010196390A1Agonist anti-trkb monoclonal antibodiesRINAT NEUROSCIENCE CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Javier Fernando Chaparro Riggers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →